- Home
- FBK vs APLS Comparison
FBK vs APLS Comparison
Compare FBK & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBK | APLS |
|---|---|---|
| Founded | 1906 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.7B |
| IPO Year | 2016 | 2017 |
Fundamental Metrics
Financial Performance| Metric | FBK | APLS |
|---|---|---|
| Price | $57.89 | $27.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 20 |
| Target Price | ★ $61.25 | $33.89 |
| AVG Volume (30 Days) | 324.3K | ★ 2.4M |
| Earning Date | 01-21-2026 | 02-27-2026 |
| Dividend Yield | ★ 1.31% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.14 | 0.36 |
| Revenue | $462,659,000.00 | ★ $1,016,397,000.00 |
| Revenue This Year | $26.58 | $28.88 |
| Revenue Next Year | $31.81 | N/A |
| P/E Ratio | ★ $27.17 | $76.23 |
| Revenue Growth | 6.02 | ★ 42.11 |
| 52 Week Low | $38.83 | $16.10 |
| 52 Week High | $60.52 | $31.17 |
Technical Indicators
Market Signals| Indicator | FBK | APLS |
|---|---|---|
| Relative Strength Index (RSI) | 56.92 | 64.42 |
| Support Level | $56.31 | $23.69 |
| Resistance Level | $57.57 | $26.68 |
| Average True Range (ATR) | 1.26 | 1.13 |
| MACD | 0.07 | 0.08 |
| Stochastic Oscillator | 67.26 | 89.68 |
Price Performance
Historical ComparisonAbout FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.